Serina Therapeutics Inc./$SER
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.
Ticker
$SER
Sector
Primary listing
AMEX
Employees
13
Headquarters
Website
SER Metrics
BasicAdvanced
$55M
-
-$1.34
-
-
Price and volume
Market cap
$55M
52-week high
$7.92
52-week low
$4.10
Average daily volume
223K
Financial strength
Current ratio
2.244
Quick ratio
1.696
Long term debt to equity
11.239
Total debt to equity
21.993
Interest coverage (TTM)
-495.43%
Profitability
EBITDA (TTM)
-20.663
Gross margin (TTM)
-8,271.54%
Net profit margin (TTM)
-9,685.38%
Operating margin (TTM)
-16,006.15%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-132.37%
Return on equity (TTM)
171.60%
Valuation
Price to revenue (TTM)
390.642
Price to book
-17.33
Price to tangible book (TTM)
-17.33
Price to free cash flow (TTM)
-3.239
Free cash flow yield (TTM)
-30.87%
Free cash flow per share (TTM)
-1.655
Growth
Revenue change (TTM)
-95.90%
Earnings per share change (TTM)
-24.97%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Serina Therapeutics Inc. stock?
Serina Therapeutics Inc. (SER) has a market cap of $55M as of September 10, 2025.
What is the P/E ratio for Serina Therapeutics Inc. stock?
The price to earnings (P/E) ratio for Serina Therapeutics Inc. (SER) stock is 0 as of September 10, 2025.
Does Serina Therapeutics Inc. stock pay dividends?
No, Serina Therapeutics Inc. (SER) stock does not pay dividends to its shareholders as of September 10, 2025.
When is the next Serina Therapeutics Inc. dividend payment date?
Serina Therapeutics Inc. (SER) stock does not pay dividends to its shareholders.
What is the beta indicator for Serina Therapeutics Inc.?
Serina Therapeutics Inc. (SER) does not currently have a Beta indicator.